# Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection

> **NCT06526455** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shicai Ye** · enrollment: 196 (estimated)

## Conditions studied

- Ulcers, Gastric

## Interventions

- **DRUG:** Vonoprazan
- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT06526455
- **Lead sponsor:** Shicai Ye
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2024-07-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06526455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06526455, "Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06526455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*